Feifei Wang

Dr. Feifei Wang


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2025 in Oncogene
Verified
Journal Article
Closed access
PDF file
FWFeifei Wang
Feifei Wang
MRMengtao Rong
Mengtao Rong
LZLiang Zhang
Liang Zhang
ASAbhishikt D. Solomon
Abhishikt D. Solomon
WGWenli Gui
Wenli Gui
APAimin Peng
Aimin Peng

26 June 2022 in Applied Organometallic Chemistry
Verified
Journal Article
Closed access
TLTong Lei
Tong Lei
ZMZhanshan Ma
Zhanshan Ma
HLHongju Liu
Hongju Liu
XWXiaoyue Wang
Xiaoyue Wang
PLPei Li
Pei Li
FWFuzhou Wang
Fuzhou Wang

4 May 2025 in Journal of Biological Chemistry
Verified
Journal Article
Open access
FWFeifei Wang
Feifei Wang
WGWenli Gui
Wenli Gui
MRMengtao Rong
Mengtao Rong
LZLiang Zhang
Liang Zhang
JWJiajing Wu
Jiajing Wu
APAimin Peng
Aimin Peng
Non-homologous end joining (NHEJ) is a pivotal mechanism in the repair of DNA double-strand breaks (DSBs). Central to NHEJ is the DNA-dependent protein kinase (DNA-PK) complex, comprising the KU heterodimer and the catalytic subunit, DNA-PKcs. In this study, we characterize TOX High Mobility Group Box Family Member 4 (TOX4) as a factor recruited to both laser-induced DNA damage and endonuclease-induced DNA DSBs. Depletion of TOX4 leads to accumulation of DNA damage, which is epistatic to DNA-PKcs. Consistently, TOX4 depletion substantially reduces NHEJ efficiency measured using both intrachromosomal and extrachromosomal repair assays. Our proteomic and biochemical analyses reveal TOX4 association with DNA-PK that is required for DNA-PKcs activation. Furthermore, we show that TOX4 coordinates with Phosphatase 1 Nuclear-Targeting Subunit (PNUTS) in NHEJ. PNUTS, previously shown to protect DNA-PKcs phosphorylation from protein phosphatase 1 (PP1)-mediated dephosphorylation, binds DNA-PK in a TOX4-dependent manner. In line with its role in DNA repair, TOX4 emerges as a promising target for anti-cancer drug development, and its targeting enhances tumor cell sensitivity to DNA damage in head and neck cancer and other malignancies.